A Add to watchlist $135.20 +1.16 (+0.87%) Last updated: Jul 15, 2026 06:03
52-Week Range
$135.20
$108.35 $135.20 $160.27

Fundamentals Overview

Agilent Technologies, Inc. is in the middle of its 52-week range with moderate valuation, trading relatively flat today.

Valuation moderate

P/E 27.2 PEG 1.28 P/B 5.37 P/S 5.28

Intrinsic value (DCF)

-45.4% downside vs price

Profitability

Net margin 19.6%

Risk (Beta)

1.26 — higher vol

Earnings & growth

EPS $4.98 Rev +2.1% Profit +11.1% vs prior qtr

BullzEye Analysis

Our composite tilts Hold on technicals (e.g. RSI, ADX, trend), fundamentals, sentiment, sector and index context, and risk.

Composite Signal

Sell
Buy
Hold — 56% confidence Risk: High Volatility — Beta 1.26. Consider smaller position size due to higher beta.

Supporting (Buy):

Analyst grade: A- · Sentiment improving (3 upgrades) · 3M vs S&P 500: +5.5% · 3M vs Healthcare sector: +8.1%

Pressures (Sell):

DCF 45.4% downside vs price

Not financial advice. For education and research only; do your own research and consider a financial advisor before investing.

Key Stats

Market Cap
$38.18B
P/E (TTM)
27.15
EPS (TTM)
$4.98
Dividend Yield
0.75%
52-Week Range
$108.35 - $160.27
Volume vs Avg
N/A
Beta
1.26

About

Agilent Technologies, Inc. delivers specialized, application-focused technologies and services to the global life sciences, diagnostics, and applied chemistry industries. Its Life Sciences and Applied Markets segment provides a comprehensive portfolio of analytical instrumentation. This includes liquid chromatography (LC) and gas chromatography (GC) systems, often integrated with mass spectrometry (MS) for advanced analysis (LC-MS, GC-MS). They also offer inductively coupled plasma mass spectrom...
Sector: Healthcare
Headquarters: US
Employees: 18,100
IPO Date: Nov 1999
Beta: 1.26 (More volatile than market)

Ratings & Grades at a Glance

Overall rating: A-. Recent institutional grades: majority upgrades. Current institutional positions: Buy: 10, Equal Weight: 1, Neutral: 2, Outperform: 6, Overweight: 10, Sector Weight: 1.

Financial story & AI narrative

Open this tab to load the financial story.

Valuation & Ratios

Valuation, liquidity, and profitability metrics are consolidated here (including ratios that previously appeared in the Financials story). Trailing (TTM) vs forward-looking (e.g. DCF) is noted on each line where it matters.

DCF vs price: DCF estimate is $73.82; current price is $135.20. That’s a -45.4% gap. When the gap is large (e.g. >20%), that’s divergence; when they’re close, that’s convergence. Differences can reflect growth expectations, sector premiums, or conservative vs. optimistic assumptions. Use DCF as one input alongside technicals and sentiment.

Metric Value
Valuation
P/E (TTM) 27.15
DCF value (model) $73.82 (-45.4% vs price)
PEG (TTM) 1.28
P/B (TTM) 5.37
P/S (TTM) 5.28
P/FCF (TTM) 30.4
Liquidity & enterprise
Current Ratio (TTM) 2.1
Quick Ratio (TTM) 1.62
Cash Ratio (TTM) 0.8
Profitability
ROE (TTM) N/A
ROA (TTM) N/A
Revenue growth (YoY) N/A
Net margin (TTM) 19.55%
Gross margin (TTM) 53%
Operating margin (TTM) 21.5%
Debt to equity (TTM) N/A

Latest News

News loads when you open this tab.

Price Target, Ratings & Grades

Analyst price targets, consensus, rating snapshot, and institutional grades for A.

Analyst Sentiment at a Glance

A- Sentiment Improving
Buy 10Equal Weight 1Neutral 2Outperform 6Overweight 10Sector Weight 1
3 upgrades, 1 downgrade
Price Target Consensus
Current $135.20
Median $152.50
Consensus $153.25
Low consensus $140.00
High consensus $165.00

Stock Grades (Institutions)

Institution Action Previous Grade New Grade Date
Evercore ISI Group maintain Outperform Outperform 2026-07-06
Barclays maintain Overweight Overweight 2026-06-24
Piper Sandler downgrade Overweight Neutral 2026-06-11
HSBC maintain Buy Buy 2026-06-03
B of A Securities maintain Buy Buy 2026-06-02
TD Cowen maintain Buy Buy 2026-05-28
Wells Fargo maintain Overweight Overweight 2026-05-28
RBC Capital maintain Outperform Outperform 2026-05-28
Barclays maintain Overweight Overweight 2026-05-28
B of A Securities upgrade Neutral Buy 2026-05-28
Baird maintain Outperform Outperform 2026-05-26
Keybanc maintain Sector Weight Sector Weight 2026-04-28
Barclays maintain Overweight Overweight 2026-04-14
TD Cowen maintain Buy Buy 2026-04-13
Evercore ISI Group maintain Outperform Outperform 2026-04-06
Morgan Stanley maintain Overweight Overweight 2026-03-03
TD Cowen maintain Buy Buy 2026-02-26
Wells Fargo maintain Overweight Overweight 2026-02-26
Barclays maintain Overweight Overweight 2026-02-26
UBS maintain Buy Buy 2026-02-26
Evercore ISI Group upgrade In Line Outperform 2026-01-05
Barclays upgrade Equal Weight Overweight 2025-12-15
Citigroup maintain Buy Buy 2025-11-25
Baird maintain Outperform Outperform 2025-11-25
UBS maintain Buy Buy 2025-11-25
B of A Securities maintain Neutral Neutral 2025-11-25
Wells Fargo maintain Overweight Overweight 2025-11-25
Barclays maintain Equal Weight Equal Weight 2025-11-25
JP Morgan maintain Overweight Overweight 2025-11-25
TD Cowen maintain Buy Buy 2025-10-14